Learn How to Pronounce Sacubitril

Quick Answer: In English, the name Sacubitril is pronounced [səˈkjuːbɪtɹɪl].
(Listen to the audio above for the stress and intonation)

The Expert's Take

Dr. Franz Lang

"This came up during a medical linguistics seminar. Drug names are often a phonetic nightmare, but "Sacubitril" has a rhythmic flow that makes it easier to remember than most. It’s a great example of how pharmaceutical companies balance science with brandability."

By Dr. Franz Lang

Meaning and Context

Sacubitril is a potent neprilysin inhibitor that represents a cornerstone of modern pharmacotherapy for heart failure. It is exclusively used in a fixed-dose combination with the angiotensin receptor blocker valsartan, forming the dual-action compound sacubitril/valsartan, which is marketed under the brand name Entresto. Approved by the U.S. Food and Drug Administration (FDA) in 2015, this combination medication revolutionized the management of chronic heart failure with reduced ejection fraction (HFrEF) by targeting the neurohormonal system in a novel way. While valsartan blocks the harmful renin-angiotensin-aldosterone system, sacubitril inhibits the enzyme neprilysin, thereby increasing the levels of beneficial natriuretic peptides that promote vasodilation, natriuresis, and diuresis. This dual mechanism has been clinically proven in pivotal trials to significantly reduce the risks of cardiovascular death and heart failure hospitalization compared to previous standard therapies, establishing it as a first-line treatment in major clinical guidelines. Its use has since expanded, with evidence supporting benefits for heart failure with preserved ejection fraction (HFpEF) as well, making it a critical tool for cardiologists and a focal point for heart failure management and cardiovascular drug development.

Common Mistakes and Alternative Spellings

The primary spelling of the drug is Sacubitril, which is the standard International Nonproprietary Name (INN). Common misspellings and typographical errors often arise from phonetic misinterpretation or keyboard slips. Frequent variants include "Sacubitril" (incorrectly capitalizing the 'b'), "Sacubitral" (substituting 'l' for 'r'), and "Sacubitrill" (adding an extra 'l'). Other errors involve blending it with its partner drug, leading to conflated terms like "valsacubitril" or "sacuvalsartan." It is also sometimes mistakenly referred to by its brand name component alone, such as calling the combination "Valsartan" without acknowledging the sacubitril, which is a significant clinical error as the efficacy is specific to the combination. In formal medical writing, it is most precisely denoted as sacubitril/valsartan to accurately reflect the combination product.

Example Sentences

Following the updated clinical guidelines, the cardiologist initiated treatment with sacubitril/valsartan to target the patient's progressive heart failure.

The landmark PARADIGM-HF trial demonstrated that sacubitril, when combined with valsartan, provided a superior mortality benefit compared to enalapril alone.

A common protocol involves titrating the dose of Entresto from sacubitril 49 mg/valsartan 51 mg twice daily to the target maintenance dose.

Patients transitioning from an ACE inhibitor must observe a 36-hour washout period before starting sacubitril to minimize the risk of angioedema.

The pharmacologic action of sacubitril, through neprilysin inhibition, increases circulating levels of atrial natriuretic peptide, aiding in reduced cardiac afterload.

Sources and References

For this pharmaceutical term, I used Wiktionary, Wikipedia, Forvo, and YouGlish, while also checking medical pronunciation guides from the American Society of Health-System Pharmacists.

Related Pronunciations

📂 Browse all words in the Drugs, Molecules and Vaccines category ➔